Dr. Tracy R. Wilson, DNP, MBE, MSN.ED., RN, FNP-C

Director, Field Medical, Antivirals, Southwest Region (South TX and NM) US Medical Affairs

Pfizer

Dr. Wilson brings more than 20 years of healthcare and patient advocacy experience, including clinical education, family nursing, nursing student instruction, and interdisciplinary course design. She holds a Doctor of Nursing Practice from Belmont University, along with a Post-master FNP certification from the University of Kentucky and Master of Science in Bioethics and Medical Humanities from Tulane School of Medicine. She also holds a Master of Science in Nursing Education from Bellarmine University.

In her current role as field medical director for antivirals at Pfizer, Dr. Wilson delivers impact by forging relationships with patient and professional advocacy organizations and coalitions. During her tenure, she has helped launch 6 new products and indications (including a novel oral antiviral FDA approved product and a new antiviral vaccine) and provided medical support and guidance for health disparities initiatives.

Early in her career, Dr. Wilson contributed as a support staff nurse for Planned Parenthood and NICU level 2 staff nurse with Kosair Children’s Hospital. It was during this time she developed a deep appreciation for the need for advocacy to support and represent the rights, needs, and preferences of patients to ensure the receipt of appropriate and quality care.

Dr. Wilson would go on to positively impact the academic side of healthcare, serving as a NCLEX review instructor with Kaplan University (2010-2013) and health assessment course coordinator at Belmont University (2014-2016). In these roles, she helped to mold the next generation of nursing professionals by preparing them to effectively advocate for their patients' rights, needs, and well-being. Concurrently, Dr. Wilson would continue hands-on bedside healthcare as a family nurse practitioner at Murfreesboro Medical Clinic from 2013 to 2018.

As a clinical educator with Thermo Fisher Scientific, Dr. Wilson was key in the launch of 23 new component assays to market, identifying and developing clinical champions and thought leaders as business advocates in the process. She would contribute 3 years in this role before joining the Pfizer team in 2019.

Recent awards received include (but are not limited to):

• President’s Award, National Black Nurse Practitioner Association, 12/2022
• Patient Impact Award for Pharmaceuticals, 11/2022
• HBU Medical Achievement Award-HBU North America Medical Affairs Team (Approaches to Addressing Health Inequities across a Large and Diverse Portfolio (US)), 12/2021
• 31 Phenomenal Women Awardee, International Women’s Day, American Caribbean Chamber of Commerce, Houston, TX, 03/2021.

Dr. Wilson has held leadership roles with the American Academy of Nurse Practitioners (South TX state liaison), American Nurses Association (ANA 1st Alternate Ethics Advisory Board member), Healthcare Businesswomen’s Association (Global Education Advisory Committee, Global Education and Event Chair), among others. She has also served extensively as a speaker, panelist, and poster presenter throughout her career.